By Marie Rosenthal
Patients with heart failure (HF) who might benefit from ivabradine (Corlanor, Amgen) were more likely to take the medication if it was prescribed before hospital discharge rather than in a follow-up doctor’s visit, according to a presentation at the American Heart Association’s Quality of Care and Outcomes Research 2019 Scientific Sessions (poster 252).
A lower heart rate is associated with better outcomes in people with HF and a reduced ejection fraction. The